BRIEF-TScan Therapeutics Q2 Net Income USD -30.359 Million
Reuters2026/08/12 11:01Aug 12 (Reuters) - TScan Therapeutics Q2 income from operations USD -30.493 million.
- Q2 operating expenses USD 31.544 million
- Q2 collaboration and license revenue USD 1.051 million
- Q2 basic EPS USD -0.23
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BridgeBio posts PROPEL 3 Phase 3 infigratinib data in children with achondroplasia presentation
Market Chatter: UnitedHealth Sells Stake in Florida Optum Health Operations to TPG
Chevron (CVX.US) invests $7 billions to bet on Venezuela! The number of oil rigs will double and daily production targets 600,000 barrels
As part of a $7 billion, five-year expansion plan, Chevron plans to more than double the number of oil rigs it operates in Venezuela in order to boost its oil production in the country to around 600,000 barrels per day.
Ford (F.US), Stellantis (STLA.US), and others aim to solve the range bottleneck with range extenders; gasoline generators become the new "power bank" for electric vehicles.
Traditional automakers such as Ford (F.US), Stellantis (STLA.US), and Hyundai Motor are planning to launch a new generation of Extended-Range Electric Vehicles (EREVs).
Crypto prices
More
